UniProt ID | TBA3C_HUMAN | |
---|---|---|
UniProt AC | Q13748 | |
Protein Name | Tubulin alpha-3C/D chain | |
Gene Name | TUBA3C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 450 | |
Subcellular Localization | Cytoplasm, cytoskeleton. | |
Protein Description | Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.. | |
Protein Sequence | MRECISIHVGQAGVQIGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFNTFFSETGAGKHVPRAVFVDLEPTVVDEVRTGTYRQLFHPEQLITGKEDAANNYARGHYTIGKEIVDLVLDRIRKLADLCTGLQGFLIFHSFGGGTGSGFASLLMERLSVDYGKKSKLEFAIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLIGQIVSSITASLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCDPRHGKYMACCMLYRGDVVPKDVNAAIATIKTKRTIQFVDWCPTGFKVGINYQPPTVVPGGDLAKVQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDLAALEKDYEEVGVDSVEAEAEEGEEY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MRECISIHVGQAG --CCCEEEEEECCHH | 20.50 | - | |
24 | Phosphorylation | GNACWELYCLEHGIQ CHHHHHCHHHHCCCC | 5.40 | - | |
38 | Phosphorylation | QPDGQMPSDKTIGGG CCCCCCCCCCCCCCC | 46.53 | - | |
40 | Ubiquitination | DGQMPSDKTIGGGDD CCCCCCCCCCCCCCC | 46.51 | 24906155 | |
40 | Acetylation | DGQMPSDKTIGGGDD CCCCCCCCCCCCCCC | 46.51 | 24906155 | |
40 | Acetylation | DGQMPSDKTIGGGDD CCCCCCCCCCCCCCC | 46.51 | 24906155 | |
41 | Phosphorylation | GQMPSDKTIGGGDDS CCCCCCCCCCCCCCC | 29.82 | - | |
48 | Phosphorylation | TIGGGDDSFNTFFSE CCCCCCCCHHHCCCC | 25.74 | 17924679 | |
51 | Phosphorylation | GGDDSFNTFFSETGA CCCCCHHHCCCCCCC | 24.85 | - | |
54 | Phosphorylation | DSFNTFFSETGAGKH CCHHHCCCCCCCCCC | 30.02 | - | |
56 | Phosphorylation | FNTFFSETGAGKHVP HHHCCCCCCCCCCCC | 31.00 | - | |
60 | Sumoylation | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | - | |
60 | Ubiquitination | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | - | |
60 | Acetylation | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | - | |
60 | Acetylation | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | 19811027 | |
60 (in isoform 1) | Ubiquitination | - | 40.68 | 21890473 | |
60 (in isoform 2) | Ubiquitination | - | 40.68 | 21890473 | |
79 | Methylation | PTVVDEVRTGTYRQL CEEEECCCCCCCHHC | 25.95 | - | |
94 | Phosphorylation | FHPEQLITGKEDAAN CCHHHHCCCCHHHHH | 51.28 | - | |
96 | Sumoylation | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | - | |
96 | Ubiquitination | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | - | |
96 | Acetylation | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | - | |
96 | Acetylation | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | 30582473 | |
96 (in isoform 1) | Ubiquitination | - | 43.71 | 21890473 | |
96 (in isoform 2) | Ubiquitination | - | 43.71 | 21890473 | |
103 | Phosphorylation | KEDAANNYARGHYTI CHHHHHHCCCCCCCC | 9.48 | - | |
108 | Phosphorylation | NNYARGHYTIGKEIV HHCCCCCCCCCHHHH | 11.68 | - | |
109 | Phosphorylation | NYARGHYTIGKEIVD HCCCCCCCCCHHHHH | 19.99 | - | |
112 | Acetylation | RGHYTIGKEIVDLVL CCCCCCCHHHHHHHH | 40.18 | 25038526 | |
156 | Methylation | FASLLMERLSVDYGK HHHHHHHHHCCCCCC | 20.49 | - | |
156 | Methylation | FASLLMERLSVDYGK HHHHHHHHHCCCCCC | 20.49 | 24390935 | |
158 | Phosphorylation | SLLMERLSVDYGKKS HHHHHHHCCCCCCCC | 21.11 | - | |
161 | Phosphorylation | MERLSVDYGKKSKLE HHHHCCCCCCCCCCE | 28.79 | - | |
163 | Methylation | RLSVDYGKKSKLEFA HHCCCCCCCCCCEEE | 47.87 | - | |
163 | Ubiquitination | RLSVDYGKKSKLEFA HHCCCCCCCCCCEEE | 47.87 | - | |
163 | Acetylation | RLSVDYGKKSKLEFA HHCCCCCCCCCCEEE | 47.87 | - | |
163 | Acetylation | RLSVDYGKKSKLEFA HHCCCCCCCCCCEEE | 47.87 | 130867 | |
163 | Methylation | RLSVDYGKKSKLEFA HHCCCCCCCCCCEEE | 47.87 | 130867 | |
163 | Ubiquitination | RLSVDYGKKSKLEFA HHCCCCCCCCCCEEE | 47.87 | 21890473 | |
163 (in isoform 1) | Ubiquitination | - | 47.87 | 21890473 | |
163 (in isoform 2) | Ubiquitination | - | 47.87 | 21890473 | |
164 | Ubiquitination | LSVDYGKKSKLEFAI HCCCCCCCCCCEEEE | 48.75 | - | |
164 | Ubiquitination | LSVDYGKKSKLEFAI HCCCCCCCCCCEEEE | 48.75 | 20972266 | |
164 (in isoform 1) | Ubiquitination | - | 48.75 | 21890473 | |
164 (in isoform 2) | Ubiquitination | - | 48.75 | 21890473 | |
165 | Phosphorylation | SVDYGKKSKLEFAIY CCCCCCCCCCEEEEE | 46.06 | - | |
210 | Phosphorylation | MVDNEAIYDICRRNL EECHHHHHHHHHCCC | 13.30 | - | |
223 | Phosphorylation | NLDIERPTYTNLNRL CCCCCCCCCCCHHHH | 49.55 | - | |
224 | Phosphorylation | LDIERPTYTNLNRLI CCCCCCCCCCHHHHH | 9.05 | - | |
225 | Phosphorylation | DIERPTYTNLNRLIG CCCCCCCCCHHHHHH | 35.39 | - | |
253 | Phosphorylation | GALNVDLTEFQTNLV CCCCCCCCEEECCCC | 30.23 | - | |
257 | Phosphorylation | VDLTEFQTNLVPYPR CCCCEEECCCCCCCC | 35.52 | - | |
272 | Phosphorylation | IHFPLATYAPVISAE CCCCCCCCCCCCCHH | 11.87 | - | |
277 | Phosphorylation | ATYAPVISAEKAYHE CCCCCCCCHHHHHHH | 30.52 | - | |
280 | Ubiquitination | APVISAEKAYHEQLS CCCCCHHHHHHHHCC | 54.70 | - | |
280 | Acetylation | APVISAEKAYHEQLS CCCCCHHHHHHHHCC | 54.70 | 88229 | |
280 | Ubiquitination | APVISAEKAYHEQLS CCCCCHHHHHHHHCC | 54.70 | 21906983 | |
280 (in isoform 1) | Ubiquitination | - | 54.70 | 21890473 | |
280 (in isoform 2) | Ubiquitination | - | 54.70 | 21890473 | |
282 | Phosphorylation | VISAEKAYHEQLSVA CCCHHHHHHHHCCHH | 19.56 | 17016520 | |
282 | Nitration | VISAEKAYHEQLSVA CCCHHHHHHHHCCHH | 19.56 | - | |
287 | Phosphorylation | KAYHEQLSVAEITNA HHHHHHCCHHHHHHH | 20.98 | - | |
304 | Ubiquitination | EPANQMVKCDPRHGK CCHHHCCCCCCCCCC | 27.81 | - | |
304 | Ubiquitination | EPANQMVKCDPRHGK CCHHHCCCCCCCCCC | 27.81 | 21890473 | |
304 (in isoform 1) | Ubiquitination | - | 27.81 | 21890473 | |
304 (in isoform 2) | Ubiquitination | - | 27.81 | 21890473 | |
311 | Acetylation | KCDPRHGKYMACCML CCCCCCCCEEEEHHH | 26.23 | 25038526 | |
326 | Sumoylation | YRGDVVPKDVNAAIA CCCCCCCCCCCHHHH | 63.80 | - | |
326 | Ubiquitination | YRGDVVPKDVNAAIA CCCCCCCCCCCHHHH | 63.80 | - | |
326 | Acetylation | YRGDVVPKDVNAAIA CCCCCCCCCCCHHHH | 63.80 | - | |
326 | Acetylation | YRGDVVPKDVNAAIA CCCCCCCCCCCHHHH | 63.80 | 22632571 | |
326 (in isoform 1) | Ubiquitination | - | 63.80 | 21890473 | |
326 (in isoform 2) | Ubiquitination | - | 63.80 | 21890473 | |
334 | Phosphorylation | DVNAAIATIKTKRTI CCCHHHHHCCCCCEE | 19.52 | - | |
336 | Sumoylation | NAAIATIKTKRTIQF CHHHHHCCCCCEEEE | 43.57 | - | |
336 | Ubiquitination | NAAIATIKTKRTIQF CHHHHHCCCCCEEEE | 43.57 | - | |
336 | Acetylation | NAAIATIKTKRTIQF CHHHHHCCCCCEEEE | 43.57 | - | |
336 | Acetylation | NAAIATIKTKRTIQF CHHHHHCCCCCEEEE | 43.57 | 23749302 | |
336 | Ubiquitination | NAAIATIKTKRTIQF CHHHHHCCCCCEEEE | 43.57 | 20639865 | |
336 (in isoform 1) | Ubiquitination | - | 43.57 | 21890473 | |
336 (in isoform 2) | Ubiquitination | - | 43.57 | 21890473 | |
337 | Phosphorylation | AAIATIKTKRTIQFV HHHHHCCCCCEEEEE | 23.16 | - | |
338 | Methylation | AIATIKTKRTIQFVD HHHHCCCCCEEEEEE | 42.41 | - | |
338 | Ubiquitination | AIATIKTKRTIQFVD HHHHCCCCCEEEEEE | 42.41 | - | |
338 | Methylation | AIATIKTKRTIQFVD HHHHCCCCCEEEEEE | 42.41 | 184311 | |
338 | Ubiquitination | AIATIKTKRTIQFVD HHHHCCCCCEEEEEE | 42.41 | 21890473 | |
338 (in isoform 1) | Ubiquitination | - | 42.41 | 21890473 | |
338 (in isoform 2) | Ubiquitination | - | 42.41 | 21890473 | |
340 | Phosphorylation | ATIKTKRTIQFVDWC HHCCCCCEEEEEEEC | 22.23 | - | |
347 | S-palmitoylation | TIQFVDWCPTGFKVG EEEEEEECCCCEEEE | 1.55 | 29575903 | |
349 | Phosphorylation | QFVDWCPTGFKVGIN EEEEECCCCEEEEEE | 52.71 | - | |
352 | Sumoylation | DWCPTGFKVGINYQP EECCCCEEEEEECCC | 40.68 | - | |
352 | Ubiquitination | DWCPTGFKVGINYQP EECCCCEEEEEECCC | 40.68 | - | |
352 | Acetylation | DWCPTGFKVGINYQP EECCCCEEEEEECCC | 40.68 | 130869 | |
357 | Phosphorylation | GFKVGINYQPPTVVP CEEEEEECCCCEECC | 22.07 | - | |
361 | Phosphorylation | GINYQPPTVVPGGDL EEECCCCEECCCCCH | 40.60 | - | |
370 | Sumoylation | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | - | |
370 | Ubiquitination | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | - | |
370 | Acetylation | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | - | |
370 | Acetylation | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | 184313 | |
370 (in isoform 1) | Ubiquitination | - | 46.31 | 21890473 | |
370 (in isoform 2) | Ubiquitination | - | 46.31 | 21890473 | |
379 | Phosphorylation | QRAVCMLSNTTAIAE HHHHHHHCCHHHHHH | 12.78 | - | |
394 | Sumoylation | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | - | |
394 | Ubiquitination | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | - | |
394 | Acetylation | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | - | |
394 | Acetylation | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | 134085 | |
394 | Ubiquitination | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | 21890473 | |
394 (in isoform 1) | Ubiquitination | - | 39.99 | 21890473 | |
399 | Phosphorylation | DHKFDLMYAKRAFVH CCCCCHHHEEEHHHH | 19.10 | - | |
401 | Sumoylation | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | - | |
401 | Ubiquitination | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | - | |
401 | Acetylation | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | - | |
401 | Acetylation | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | 130865 | |
401 | Ubiquitination | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | 21890473 | |
401 (in isoform 1) | Ubiquitination | - | 27.11 | 21890473 | |
419 | Phosphorylation | GMEEGEFSEAREDLA CCCCCCHHHHHHHHH | 26.50 | - | |
439 | Phosphorylation | YEEVGVDSVEAEAEE HHHHCCCCCCCHHHC | 21.32 | - | |
450 | Nitration | EAEEGEEY------- HHHCCCCC------- | 21.39 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TBA3C_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBA3C_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NMI_HUMAN | NMI | physical | 16189514 | |
TCPG_HUMAN | CCT3 | physical | 26186194 | |
TTC5_HUMAN | TTC5 | physical | 26186194 | |
TXND9_HUMAN | TXNDC9 | physical | 26186194 | |
T11L2_HUMAN | TCP11L2 | physical | 26186194 | |
TBA1A_HUMAN | TUBA1A | physical | 26186194 | |
TBA1C_HUMAN | TUBA1C | physical | 26186194 | |
MFS4B_HUMAN | KIAA1919 | physical | 26186194 | |
TBB4B_HUMAN | TUBB4B | physical | 26344197 | |
T11L2_HUMAN | TCP11L2 | physical | 28514442 | |
TXND9_HUMAN | TXNDC9 | physical | 28514442 | |
TTC5_HUMAN | TTC5 | physical | 28514442 | |
TBA1A_HUMAN | TUBA1A | physical | 28514442 | |
MFS4B_HUMAN | KIAA1919 | physical | 28514442 | |
TCPB_HUMAN | CCT2 | physical | 28514442 | |
TCPG_HUMAN | CCT3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND THR-51, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND MASSSPECTROMETRY. |